1. Home
  2. ARBE vs LONA Comparison

ARBE vs LONA Comparison

Compare ARBE & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbe Robotics Ltd.

ARBE

Arbe Robotics Ltd.

HOLD

Current Price

$0.68

Market Cap

79.1M

Sector

Technology

ML Signal

HOLD

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$7.30

Market Cap

81.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARBE
LONA
Founded
2015
2011
Country
Israel
United States
Employees
144
19
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.1M
81.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARBE
LONA
Price
$0.68
$7.30
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$2.38
$10.00
AVG Volume (30 Days)
1.8M
36.6K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$363.94
N/A
Revenue Next Year
$286.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$4.21
52 Week High
$2.88
$14.21

Technical Indicators

Market Signals
Indicator
ARBE
LONA
Relative Strength Index (RSI) 41.82 39.63
Support Level $0.65 $7.00
Resistance Level $0.90 $9.78
Average True Range (ATR) 0.06 0.71
MACD 0.00 -0.14
Stochastic Oscillator 6.52 12.24

Price Performance

Historical Comparison
ARBE
LONA

About ARBE Arbe Robotics Ltd.

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: